---
layout: post
title: 'USAN Watch: February 2013'
date: '2013-02-17T20:15:00.002Z'
author: John Overington
tags:
- INNS and USANS
modified_time: '2013-02-17T20:17:13.914Z'
thumbnail: http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s72-c/inns+and+usans.png
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-6239317348071598964
blogger_orig_url: http://chembl.blogspot.com/2013/02/usan-watch-february-2013.html
---

<div class="separator" style="clear: both; text-align: center;">
<a href="http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s1600/inns+and+usans.png"><img border="0" src="http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s1600/inns+and+usans.png" /></a></div>
<span class="Apple-style-span" style="font-family: inherit;">The USANs for February 2013 have recently been published.</span><br />
<br />
<table border="1"><tbody>
<tr><td><b><span class="Apple-style-span" style="font-family: inherit;">USAN </span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Research Code </span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Structure</span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Drug Class</span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Therapeutic class</span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Target</span></b></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/avarofloxacin.pdf">avarofloxacin</a></td><td><div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
<span style="font-size: 12pt;"><span style="font-family: inherit;">JNJ-Q2, JNJ-32729463-AAA&nbsp;</span></span></div>
</div>
</div>
</td><td></td><td>synthetic small molecule</td><td>therapeutic</td><td>topo II</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/dianexin.pdf">dianexin</a></td><td>ASP-8597</td><td></td><td>protein</td><td>therapeutic</td><td></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/eldelumab.pdf">eldelumab</a></td><td><div class="page" title="Page 2">
<div class="layoutArea">
<div class="column">
<span style="font-size: 12pt;"><span style="font-family: inherit;">BMS-936557, MDX-1100</span></span><span style="font-family: 'ArialMT'; font-size: 12.000000pt;">&nbsp;</span></div>
</div>
</div>
</td><td></td><td>monoclonal antibody</td><td>therapeutic </td><td>CXCL10</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/eluxadoline.pdf">eluxadoline</a></td><td><div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
<span style="font-size: 12pt;"><span style="font-family: inherit;">JNJ-27018966</span></span><span style="font-family: 'ArialMT'; font-size: 12.000000pt;">&nbsp;</span></div>
</div>
</div>
</td><td></td><td>synthetic small molecule</td><td>therapeutic </td><td>mu Opioid R, delta Opioid R</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/formofilcon-a.pdf">formofilcon A</a></td><td></td><td></td><td>polymer</td><td>contact lens polymer</td><td>n/a</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/galunisertib.pdf">galunisertib</a></td><td><div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
<span style="font-size: 12pt;"><span style="font-family: inherit;">LY-2157299&nbsp;</span></span></div>
</div>
</div>
</td><td></td><td>synthetic small molecule</td><td>therapeutic </td><td>TGFBetaR1 TGFBetaR2</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/guselkumab.pdf">guselkumab</a></td><td><div class="page" title="Page 2">
<div class="layoutArea">
<div class="column">
<span style="font-size: 12pt;"><span style="font-family: inherit;">CNTO-1959&nbsp;</span></span></div>
</div>
</div>
</td><td></td><td>monoclonal antibody</td><td>therapeutic </td><td>IL23</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/ledipasvir.pdf">ledipasvir</a></td><td>GS-5885</td><td></td><td>synthetic small molecule</td><td>therapeutic </td><td>HCV NS5A</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/liafensine.pdf">liafensine</a></td><td>BMS-820836</td><td></td><td>synthetic small molecule</td><td>therapeutic </td><td></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/margetuximab.pdf">margetuximab</a></td><td><div class="page" title="Page 2">
<div class="layoutArea">
<div class="column">
<span style="font-size: 12pt;"><span style="font-family: inherit;">MGAH22&nbsp;</span></span></div>
</div>
</div>
</td><td></td><td>monoclonal antibody</td><td>therapeutic </td><td>ERBB2</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/mavatrep.pdf">mavatrep</a></td><td><div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
<span style="font-size: 12pt;"><span style="font-family: inherit;">JNJ-39439335&nbsp;</span></span></div>
</div>
</div>
</td><td></td><td>synthetic small molecule</td><td>therapeutic </td><td></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/methylsamidorphan.pdf">methylsamidorphan</a></td><td><div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
<span style="font-size: 12pt;"><span style="font-family: inherit;">ALKS-37, RDC-1036-00&nbsp;</span></span></div>
</div>
</div>
</td><td></td><td>natural product-derived small molecule</td><td>therapeutic </td><td>Opioid receptors</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/palbociclib.pdf">palbociclib</a></td><td><div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
<span style="font-size: 12pt;"><span style="font-family: inherit;">PD-0332991&nbsp;</span></span></div>
</div>
</div>
</td><td></td><td>synthetic small molecule</td><td>therapeutic </td><td>CDK4 CDK6</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/pegbovigrastim.pdf">pegbovigrastim</a></td><td><div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
<span style="font-size: 12pt;"><span style="font-family: inherit;">LY-2953726&nbsp;</span></span></div>
</div>
</div>
</td><td></td><td>protein</td><td>therapeutic </td><td>CSFR</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/pevonedistat.pdf">pevonedistat</a></td><td>MLN-4924</td><td></td><td>synthetic small molecule</td><td>therapeutic </td><td>NAE</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/quilizumab.pdf">quilizumab</a></td><td><div class="page" title="Page 2">
<div class="layoutArea">
<div class="column">
<span style="font-size: 12pt;"><span style="font-family: inherit;">RG-7449, MEP-1972A, Anti-M1â€™, Anti-M1 prime</span></span><span style="font-family: 'ArialMT'; font-size: 12.000000pt;">&nbsp;</span></div>
</div>
</div>
</td><td></td><td>monoclonal antibody</td><td>therapeutic </td><td>IgE M1'</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/sisapronil.pdf">sisapronil</a></td><td><span style="font-family: inherit;">PF-0241851</span></td><td></td><td>synthetic small molecule</td><td>therapeutic </td><td></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/technetium-tc-99m-trofolastat.pdf">technetium Tc 99m trofolastat</a></td><td><div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
<span style="font-family: inherit;"><span style="font-size: 12pt;">MIP-Tc-1404, MIP-</span><span style="font-size: 8pt; vertical-align: 6pt;">99m</span><span style="font-size: 12pt;">Tc-1404&nbsp;</span></span></div>
</div>
</div>
</td><td><br /></td><td>synthetic small molecule</td><td>imaging agent</td><td>PSMA</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/tovetumab.pdf">tovetumab</a></td><td>MEDI-575</td><td></td><td>monoclonal antibody</td><td>therapeutic </td><td>PDGFRa</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/vantictumab.pdf">vantictumab</a></td><td><div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
<span style="font-size: 12pt;"><span style="font-family: inherit;">OMP-18R5&nbsp;</span></span></div>
</div>
</div>
</td><td></td><td>monoclonal antibody</td><td>therapeutic </td><td>Frizzled</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/vatiquinone.pdf">vatiquinone</a></td><td>EPI-743</td><td></td><td>synthetic small molecule</td><td>therapeutic </td><td>NQO1</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/vedroprevir.pdf">vedroprevir</a></td><td>GS-9451</td><td></td><td>synthetic small molecule</td><td>therapeutic </td><td>HCV NS3 PR</td></tr>
</tbody></table>
<br />
jpo
